Summary
Background
Oxidative stress is well believed to play a role in the pathogenesis of acute ischemic stroke. Reports on antioxidant enzyme activities in patients with stroke are conflicting. Therefore, the aim of this study was to investigate serum antioxidant enzyme activities and oxidative stress levels in patients with acute ischemic stroke within 1st, 5th, and 21st day after stroke onset and also the relationship between these results and the clinical status of patients.
Methods
The current study comprised 45 patients with acute ischemic stroke and 30 healthy controls. Serum malondialdehyde (MDA) levels, superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and catalase activities were measured spectrophotometrically.
Results
Serum MDA levels were significantly higher in acute ischemic stroke patients within 24 h after stroke onset than controls (p < 0.05), whereas serum catalase activity was significantly lower (p < 0.05). There were no significant differences in GSH-Px and SOD activities.
Serum catalase and SOD activities were significantly lower in fifth day than those of controls (both, p < 0.05) but GSH-Px activity and MDA levels did not change (p > 0.05). Serum SOD activity was significantly lower in 21st day compared to SOD activity of controls (p < 0.05) but MDA levels, GSH-Px, and CAT activities did not change significantly.
Conclusions
Our study demonstrated that acute ischemic stroke patients have increased oxidative stress and decreased antioxidant enzymes activities. These findings indicated that an imbalance of oxidant and antioxidant status might play a role in the pathogenesis of acute ischemic stroke.
Similar content being viewed by others
References
Adams H, Bendixen B, Kappelle L, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1999;24:35–41.
Chen YC, Wu JS, Yang ST, et al. Stroke, angiogenesis and phytochemicals. Front Biosci (Schol Ed). 2012;4:599–610.
Ames BN, Shigenega MT, Hagen M. Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci U S A. 1993;90:7915–22.
Love S. Oxidative stress in brain ischaemia. Brain Pathol. 1999;9:119–31.
Braughler JM, Duncan LA, Chase RL. The involvement of iron in lipid peroxidation. J Biol Chem. 1986;261:10282–9.
Moro MA, Almedia A, Bolanos JP, Lizasoain I. Mitochondrial respiratory chain and free radical generation in stroke. Free Radic Biol Med. 2005;39:1291–304.
Alexandrova ML, Bochev PG. Oxidative stress during the chronic phase of stroke. Free Radic Biol Med. 2005;39:297–316.
Weigand M, Laipple A, Plaschke K, Eckstein HH, Martin E, Bardenheuer HJ. Concentration changes of malondialdehyde across the cerebral vascular bed and shedding of L-selection during carotid endarterectomy. Stroke. 1999;30:306–11.
Imre SG, Fekete I, Farkas T. Increased proportion of decosahexanoic acid and high lipid peroxidation capacity in erythrocytes of stroke patients. Stroke. 1994;25:2416–20.
El Kossi MMH Zakhary MM. Oxidative stress in the context of acute cerebrovascular stroke. Stroke. 2000;31:1889–992.
Skochii PH, Korol HM, Tymochko MF. The characteristics of lipid peroxidation in patients with an acute disorder of the cerebral circulation. Lik Sprava. 1992;6:94–6.
Aygul R, Kotan D, Demirbas F, Ulvi H, Deniz O. Plasma oxidants and antioxidants in acute ischaemic stroke. J Int Med Res. 2006;34:413–8.
Zimmermann C, Winnefeld K, Streck S, Roskos M, Haberl RL. Antioxidant status in acute stroke patients and patients at stroke risk. Eur Neurol. 2004;51:157–61.
Cojocaru IM, Cojocaru M, Sapira V, Ionescu A. Evaluation of oxidative stress in patients with acute ischemic stroke. Rom J Intern Med. 2013;51:97–106.
Ozkul A, Akyol A, Yenisey C, Arpaci E, Kiylioglu N, Tataroglu C. Oxidative stress in acute ischemic stroke. J Clin Neurosci. 2007;14:1062–6.
Strand T, Marklund SL. Release of superoxide dismutase into cerebrospinal fluid as a marker of brain lesion in acute cerebral infarction. Stroke. 1992;23:515–8.
Ishibashi N, Prokopenko O, Weisbrot-Lefkowitz M, Reuhl KR, Mirochnitchenko O. Glutathione peroxidase inhibits cell death and glial activation following experimental stroke. Brain Res Mol Brain Res. 2002;109:34–44.
Michiels C, Raes M, Toussaint O, Remacle J. Importance of Se- glutathione peroxidase, catalase and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med. 1994;17:235–48.
Spranger M, Krempien S, Schwab S, Donnenberg S, Hacke W. Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury: correlation with clinical course and infarct size. Stroke. 1997;28:2425–8.
Cherubini A, Polidori MC, Bregnocchi M, et al. Antioxidant profile and early outcome in stroke patients. Stroke. 2000;31:2295–300.
Demirkaya S, Topcuoglu MA, Aydin A, Ulas UH, Isimer AI, Vural O. Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. Eur J Neurol. 2001;8:43–51.
Weisbrot-Lefkowitz M, Reuhl K, Perry B, Chan PH, Inouye M, Mirochnitchenko O. Overexpression of human glutathione peroxidase protects transgenic mice against focal cerebral ischemia/reperfusion damage. Brain Res Mol Brain Res. 1998;53:333–8.
Kocaturk PA, Akbostanci MC, Isikay C, et al. Antioxidant status in cerebrovascular accident. Biol Trace Elem Res. 2001;80:115–24.
Aebi H. Catalase. In: Bergmeyer HU, Editors. Methods of enzymatic analysis. New York: Academic Press; 1974. p. 673–7.
Placer ZA, Cushman LL, Johnson BC. Estimation of products of lipid peroxidation (as malonyldialdhyde) in biochemical systems. Anal Biochem. 1966;16:359–64.
Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun. 1976;71:952–8.
Matkovics B, Szabo L, Varga IS. Determination of enzyme activities in lipid peroxidation and glutathione pathways (in Hungarian). Lab Diagn. 1988;15:248–9.
McCord JM, Fridovich I. Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244:6049–55.
Martin JMH, Elliot D. OPCS Survey of Disability in Great Britain Report I: the prevalence of disability among adults. London: Office of Population Cencus and Survey; 1998.
Corrêa Mde C, Maldonado P, da Rosa CS, et al. Oxidative stress and erythrocyte acetylcholinesterase (AChE) in hypertensive and ischemic patients of both acute and chronic stages. Biomed Pharmacother. 2008;62:317–24.
Alonso de Leciñana M, Egido JA, Fernández C, et al., PIVE Study Investigators of the Stroke Project of the Spanish Cerebrovascular Diseases Study Group. Risk of ischemic stroke and lifetime estrogen exposure. Neurology. 2007;68:33–8.
Yousuf S, Atif F, Ahmad M, et al. Selenium plays a modulatory role against cerebral ischemia-induced neuronal damage in rat hippocampus. Brain Res. 2007;1147:218–25.
Sun M, Zhao Y, Gu Y, Xu C. Inhibition of nNOS reduces ischemic cell death through down-regulating calpain and caspase-3 after experimental stroke. Neurochem Int. 2009;54:339–46.
Wang X, Michaelis EK. Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci. 2010;2:12–25.
Leinonen JS, Ahonen JP, Lonnrot K, et al. Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke. 2000;31:33–9.
Sharpe PC, Mulholland C, Trinick T. Ascorbate and malondialdehyde in stroke patients. Ir J Med Sci. 1994;163:488–91.
Imre SG, Fekete I, Farkas T. Increased proportion of docosahexanoic acid and high lipid peroxidation capacity in erythrocytes of stroke patients. Stroke. 1994;25:2416–20.
Ferretti G, Bacchetti T, Masciangelo S, et al. Lipid peroxidation in stroke patients. Clin Chem Lab Med. 2008;46:113–7.
Karahocagil MK, Aslan M, Ceylan MR, et al. Serum myeloperoxidase activity and oxidative stress in patients with acute brucellosis. Clin Biochem. 2012;45:733–6.
Sheikh N, Tavilani H, Rezaie A, Vaisi-raygani A, Salimi S. Relationship between estradiol and antioxidant enzymes activity of ischemic stroke. J Biomed Biotechnol. 2009;2009:1–5, 841468. doi:10.1155/2009/841468.
Catal’a A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids. 2009;157:1–11.
Ullegaddi R, Powers HJ, Gariballa SE. Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke. Eur J Clin Nutr. 2005;59:1367–73.
Acknowledgments
The authors thank the staffs of Yuzuncu Yil University, Medical Biology Department for their generous and friendly assistance in every step of this study.
Conflict of interest
The authors declared that there was no conflict of interest and indicated that they did not have a financial relationship with the organization that sponsored the research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Milanlioglu, A., Aslan, M., Ozkol, H. et al. Serum antioxidant enzymes activities and oxidative stress levels in patients with acute ischemic stroke: influence on neurological status and outcome. Wien Klin Wochenschr 128, 169–174 (2016). https://doi.org/10.1007/s00508-015-0742-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-015-0742-6